Skip to search formSkip to main contentSkip to account menu

CDAN1 wt Allele

Known as: Discs Lost, Drosophila, Homolog of Gene, CDAI, PRO1295 
Human CDAN1 wild-type allele is located in the vicinity of 15q15.2 and is approximately 14 kb in length. This allele, which encodes codanin-1 protein… 
National Institutes of Health

Related topics

Related topics

3 relations
15q15.2Congenital dyserythropoietic anemia

Broader (1)

CDAN1 gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS…
PURPOSE This phase I trial was designed to (1) establish the dose of O6-benzylguanine (O6-BG) administered intravenously as a… 
Highly Cited
2006
Highly Cited
2006
Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study.
BACKGROUND 7-Hydroxystaurosporine (UCN-01) inhibits serine-threonine kinases including the Ca2+ and phospholipid-dependent… 
Highly Cited
2005
Highly Cited
2005
Management of Recent Onset Crohn’s Disease: A Controlled, Randomized Trial Comparing Step-up and Top-down Therapy
Introduction: Current management of moderate/severe CD patients failing 5-ASA consists of glucocorticosteroids (GCS), resulting… 
Highly Cited
2003
Highly Cited
2003
Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer.
PURPOSE To identify the maximum-tolerated dose and dose-limiting toxicity (DLT) of weekly irinotecan combined with cisplatin and… 
Highly Cited
2003
Highly Cited
2003
Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial.
PURPOSE Preclinical studies indicate positive interactions between capecitabine, an oral fluorouracil precursor, and gemcitabine… 
Highly Cited
2000
Highly Cited
2000
Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal…
The purpose of our study was to determine the maximally tolerated dose (MTD) and DLT of combined administration of granulocyte… 
Highly Cited
1999
Highly Cited
1999
Assessing activity of pediatric Crohn's disease: which index to use?
Highly Cited
1999
Highly Cited
1999
Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancer.
PURPOSE Platinum-based chemotherapy currently represents standard treatment for advanced non-small-cell lung cancer. Gemcitabine… 
Highly Cited
1998
Highly Cited
1998
Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors.
PURPOSE Paclitaxel and gemcitabine possess broad spectra of clinical activity, distinct mechanisms of cytotoxicity, and are… 
Highly Cited
1996
Highly Cited
1996
Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies.
Reactivation of cytomegalovirus (CMV) is a major cause of morbidity and mortality following allogeneic bone marrow… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)